NM_002863.5:c.664G>A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002863.5(PYGL):​c.664G>A​(p.Val222Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0679 in 1,610,242 control chromosomes in the GnomAD database, including 4,607 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.095 ( 925 hom., cov: 32)
Exomes 𝑓: 0.065 ( 3682 hom. )

Consequence

PYGL
NM_002863.5 missense

Scores

7
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 4.12
Variant links:
Genes affected
PYGL (HGNC:9725): (glycogen phosphorylase L) This gene encodes a homodimeric protein that catalyses the cleavage of alpha-1,4-glucosidic bonds to release glucose-1-phosphate from liver glycogen stores. This protein switches from inactive phosphorylase B to active phosphorylase A by phosphorylation of serine residue 15. Activity of this enzyme is further regulated by multiple allosteric effectors and hormonal controls. Humans have three glycogen phosphorylase genes that encode distinct isozymes that are primarily expressed in liver, brain and muscle, respectively. The liver isozyme serves the glycemic demands of the body in general while the brain and muscle isozymes supply just those tissues. In glycogen storage disease type VI, also known as Hers disease, mutations in liver glycogen phosphorylase inhibit the conversion of glycogen to glucose and results in moderate hypoglycemia, mild ketosis, growth retardation and hepatomegaly. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017901957).
BP6
Variant 14-50921064-C-T is Benign according to our data. Variant chr14-50921064-C-T is described in ClinVar as [Benign]. Clinvar id is 258846.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.181 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PYGLNM_002863.5 linkc.664G>A p.Val222Ile missense_variant Exon 6 of 20 ENST00000216392.8 NP_002854.3 P06737-1
PYGLNM_001163940.2 linkc.562G>A p.Val188Ile missense_variant Exon 5 of 19 NP_001157412.1 P06737-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PYGLENST00000216392.8 linkc.664G>A p.Val222Ile missense_variant Exon 6 of 20 1 NM_002863.5 ENSP00000216392.7 P06737-1
PYGLENST00000532462.5 linkc.664G>A p.Val222Ile missense_variant Exon 6 of 20 1 ENSP00000431657.1 E9PK47
PYGLENST00000544180.6 linkc.562G>A p.Val188Ile missense_variant Exon 5 of 19 2 ENSP00000443787.1 P06737-2
PYGLENST00000553872.1 linkn.465G>A non_coding_transcript_exon_variant Exon 1 of 3 5

Frequencies

GnomAD3 genomes
AF:
0.0950
AC:
14451
AN:
152086
Hom.:
924
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.185
Gnomad AMI
AF:
0.113
Gnomad AMR
AF:
0.0484
Gnomad ASJ
AF:
0.0866
Gnomad EAS
AF:
0.0164
Gnomad SAS
AF:
0.0865
Gnomad FIN
AF:
0.0546
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0649
Gnomad OTH
AF:
0.0786
GnomAD3 exomes
AF:
0.0694
AC:
17431
AN:
251334
Hom.:
835
AF XY:
0.0693
AC XY:
9416
AN XY:
135830
show subpopulations
Gnomad AFR exome
AF:
0.189
Gnomad AMR exome
AF:
0.0315
Gnomad ASJ exome
AF:
0.0942
Gnomad EAS exome
AF:
0.00745
Gnomad SAS exome
AF:
0.0923
Gnomad FIN exome
AF:
0.0532
Gnomad NFE exome
AF:
0.0685
Gnomad OTH exome
AF:
0.0697
GnomAD4 exome
AF:
0.0651
AC:
94945
AN:
1458038
Hom.:
3682
Cov.:
30
AF XY:
0.0662
AC XY:
48018
AN XY:
725638
show subpopulations
Gnomad4 AFR exome
AF:
0.185
Gnomad4 AMR exome
AF:
0.0342
Gnomad4 ASJ exome
AF:
0.0903
Gnomad4 EAS exome
AF:
0.0357
Gnomad4 SAS exome
AF:
0.0931
Gnomad4 FIN exome
AF:
0.0566
Gnomad4 NFE exome
AF:
0.0614
Gnomad4 OTH exome
AF:
0.0657
GnomAD4 genome
AF:
0.0950
AC:
14463
AN:
152204
Hom.:
925
Cov.:
32
AF XY:
0.0929
AC XY:
6916
AN XY:
74406
show subpopulations
Gnomad4 AFR
AF:
0.184
Gnomad4 AMR
AF:
0.0483
Gnomad4 ASJ
AF:
0.0866
Gnomad4 EAS
AF:
0.0164
Gnomad4 SAS
AF:
0.0865
Gnomad4 FIN
AF:
0.0546
Gnomad4 NFE
AF:
0.0649
Gnomad4 OTH
AF:
0.0773
Alfa
AF:
0.0694
Hom.:
971
Bravo
AF:
0.0966
TwinsUK
AF:
0.0566
AC:
210
ALSPAC
AF:
0.0545
AC:
210
ESP6500AA
AF:
0.183
AC:
807
ESP6500EA
AF:
0.0649
AC:
558
ExAC
AF:
0.0759
AC:
9219
Asia WGS
AF:
0.0530
AC:
183
AN:
3478
EpiCase
AF:
0.0653
EpiControl
AF:
0.0694

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Apr 14, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

May 05, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Glycogen storage disease, type VI Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Uncertain
0.030
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.29
.;.;T
Eigen
Benign
0.13
Eigen_PC
Uncertain
0.30
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.93
D;D;D
MetaRNN
Benign
0.0018
T;T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
1.8
.;.;L
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-0.86
N;N;N
REVEL
Uncertain
0.38
Sift
Benign
0.11
T;T;T
Sift4G
Benign
0.25
T;T;T
Polyphen
0.016
B;.;B
Vest4
0.066
MPC
0.097
ClinPred
0.025
T
GERP RS
5.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.29
gMVP
0.57

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs946616; hg19: chr14-51387782; API